Association of HLA-DRB1*14, -DRB1*16 and -DQB1*05 with MuSK-myasthenia gravis in patients from Turkey


Alahgholi-Hajibehzad M., Yilmaz V., Gulsen-Parman Y., Aysal F., Oflazer P., Deymeer F., ...More

Human Immunology, vol.74, no.12, pp.1633-1635, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 74 Issue: 12
  • Publication Date: 2013
  • Doi Number: 10.1016/j.humimm.2013.08.271
  • Journal Name: Human Immunology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1633-1635
  • Istanbul University Affiliated: Yes

Abstract

Susceptibility to myasthenia gravis (MG) has been demonstrated with several HLA in different disease subgroups. HLA-DR14, -DR16 and -DQ5 were reported as predisposing factors in muscle-specific kinase antibody positive MG (MuSK-MG). These markers were evaluated in MG subgroups from Turkey. Among 164 generalized MG patients, 116 had antibodies against anti-acetylcholine receptor (AChR-MG) and 48 had MuSK-MG. Only HLA-DRB1 and DQB1 allele groups reported to be associated with MuSK-MG were compared with 250 healthy controls (HC). Highly significant associations of both DRB1*16 and DRB1*14 were found with MuSK-MG compared to HC (p=1.9×10-5, OR: 4.95 and p=0.0028, OR: 3.1). On the contrary, HLA-DRB1*03 was less frequent in MuSK-MG (p=0.006, OR: 0.09). DQB1*05 was also associated with MuSK-MG (p=2.5×10-6 OR: 4.8). This study provides a replication of the highly significant associations of both HLA-DRB1*16,-DRB1*14 and -DQB1*05 with MuSK-MG. Moreover, HLA-DRB1*03 appears to have a distinguishing role for this disease subgroup compared to early-onset and AChR-MG. © 2013 American Society for Histocompatibility and Immunogenetics.